Back to Ingredient Dictionary

Common Name(s): Sepiwhite msh,n-undecylenoyl-l-phenylalanine

CAS Number: 175357-18-3

DESCRIPTION

What It Does: Prevents melanocyte activation by alpha-msh signaling – a pre-enzymatic brightening mechanism distinct from all tyrosinase inhibitors.

Why It's Used: Unique brightening mechanism targeting mc1 receptor upstream of tyrosinase – the only common brightener targeting melanocyte activation rather than melanin synthesis, providing complementary synergistic activity with tyrosinase inhibitors.

How It Works: Competes with alpha-msh for binding to mc1 receptor on melanocytes. prevents receptor activation, reducing camp accumulation and creb-mediated mitf transcription factor upregulation, blocking the entire downstream cascade before tyrosinase expression.

Typically Found In: Brightening serums,uv-darkening prevention,melasma products

TECHNICAL DETAILS

Primary Category: Active ingredient – msh receptor modulator

Secondary Functions: Msh receptor competition,pre-enzymatic brightening,uv darkening prevention

Application Areas:

Facial Skincare

Body Care

Hair Care

Beard Care

Color Cosmetics (Makeup)

Dietary/Oral Supplements

Typical Concentration Range: 2%–5%

SOURCING & ETHICS

Vegan Status: Yes – synthetic

Halal Status: Yes

Source Notes: Synthetic or plant-derived.

SKIN COMPATIBILITY

Irritancy Rating: 1/5 – very low

Comedogenicity Rating: 0/5 – non-comedogenic

Sensitivity Concerns: Non-irritating; well-tolerated.

Safe for Sensitive Skin: Yes

SAFETY & COMPATIBILITY

Safety Profile: Excellent safety profile. use with spf for maximum efficacy. ewg score: 1.

Works Well With: Niacinamide,vitamin c,alpha-arbutin,tranexamic acid,spf

Avoid Combining With: No significant incompatibilities

SCIENTIFIC NOTE

Sepiwhite msh's mc1 receptor competitive antagonism targets the very first step of uv-induced melanogenesis – before any enzymatic step, mitf transcription, or tyrosinase expression. this upstream blockade potentially provides better uv-darkening prevention than tyrosinase inhibitors that act only after melanocyte activation has already occurred.

Last Verified: 2026-03-12

Primary Sources: Cosing database,grimes et al. undecylenoyl phenylalanine study,seppic technical data